Filter
6331
Text search:
drug
use
Featured
Recommendations
567
New Publications
1584
Language
Document type
No document type
3692
Studies & Reports
988
Guidelines
838
Manuals
296
Strategic & Response Plan
191
Fact sheets
122
Training Material
97
Infographics
29
Situation Updates
28
Resource Platforms
19
Brochures
16
Online Courses
10
Videos
2
Dashboards/Maps
1
App
1
Countries / Regions
India
374
Global
209
Kenya
182
South Africa
156
Ethiopia
135
Uganda
134
Western and Central Europe
133
Nigeria
118
Tanzania
111
Nepal
107
Malawi
94
Sierra Leone
93
Liberia
92
Zambia
92
Africa
88
Latin America and the Carribbean
86
Myanmar / Burma
85
Bangladesh
80
Ghana
79
Ukraine
73
Eastern Europe
71
Rwanda
68
Namibia
64
Philippines
54
Russia
51
Zimbabwe
48
Asia
46
South–East Asia Region
42
Cambodia
40
Lesotho
38
Indonesia
32
Brazil
30
Botswana
30
Congo, Democratic Republic of
29
Syria
29
Mozambique
29
Eswatini/ Swaziland
24
Senegal
22
East and Southern Africa
22
Burkina Faso
21
Germany
21
West and Central Africa
19
Middle East and North Africa
19
Cameroon
17
Haiti
17
South Sudan
17
USA
16
Colombia
16
Eastern Europe and Central Asia
15
Venezuela
14
Albania
13
Tajikistan
13
Pakistan
12
Thailand
12
Guinea
11
China
11
Georgia
11
Vietnam
11
Afghanistan
10
Sudan
9
Benin
9
Argentina
9
Moldova
9
Paraguay
8
Laos
8
Peru
7
Sri Lanka
7
Chile
7
Yemen
7
Armenia
7
Mali
6
North Macedonia
6
Mexico
6
Western Pacific Region
6
North America
6
Somalia
5
Iraq
5
Jordan
5
Lebanon
5
Central African Republic
5
Ecuador
5
El Salvador
5
Spain
5
Turkey
4
Papua New Guinea
4
Bolivia
4
Libya
4
Angola
4
Bhutan
4
Timor Leste/ East Timor
4
Estonia
4
Iran
4
Jamaica
4
United Kingdom
4
Guinea-Bissau
3
Switzerland
3
Honduras
3
Madagascar
3
Fiji
3
Palestine
3
Uzbekistan
3
Kyrgyzstan
3
Uruguay
3
Belarus
3
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Saudi Arabia
2
Chad
2
Serbia
2
Hungary
2
Guatemala
2
Nicaragua
2
Poland
2
Mongolia
2
Southern Africa
2
Canada
2
Romania
2
Kazakhstan
2
Gabon
2
Belgium
2
France
2
Portugal
2
Niger
1
Egypt
1
Gambia
1
Malaysia
1
Ireland
1
Singapore
1
Dominican Republic
1
Austria
1
Greece
1
Solomon Islands
1
North Korea
1
Italy
1
Congo-Brazzaville
1
Qatar
1
Bulgaria
1
Lithuania
1
Australia
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
2392
Clinical Guidelines
549
Public Health
287
Women & Child Health
234
Key Resources
169
Capacity Building
105
Pharmacy & Technologies
77
Annual Report MEDBOX
1
Toolboxes
HIV
749
Mental Health
678
TB
576
AMR
315
COVID-19
304
NTDs
256
Pharmacy
201
NCDs
149
Caregiver
123
Malaria
112
Ebola & Marburg
94
Refugee
82
Rapid Response
76
Planetary Health
76
Conflict
67
Disability
66
Global Health Education
57
Health Financing Toolbox
49
2.0 Rapid Response
29
Cholera
25
Polio
25
Natural Hazards
23
Specific Hazards
22
Zika
21
Social Ethics
19
Introduction
Capter A.1
Ethics and international child and adolescent psychiatry
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities
...
In 2015, to advance the global and national response to antimicrobial resistance (AMR), the World Health Assembly issued resolution WHA68.7 calling for all Member States to develop AMR national action plans that address the five objectives of the World Health Organization Global Action Plan (GAP) by
...
In 1997, the Fiftieth World Health Assembly adopted resolution WHA50.29 on the elimination of
lymphatic filariasis as a public health problem. Preliminary guidance from WHO printed in 2011 referred to “verification” as the official process by which the achievements of the Global Programme to El
...
This guide can be used to train medical officers to ensure BP is measured for all adults visiting the OPD, treat all patients with high BP, initiate treatment as per protocol, counsel patients for follow-up, refer patients to local care, and report data.
Updated Guidelines
4–15 February 2013
Epilepsies: diagnosis and management
recommended
Clinical guideline | Published: 11 January 2012 | nice.org.uk/guidance/cg137
Q4: In individuals with long term and/or recurrent psychotic disorders (including schizophrenia), should individuals be maintained on pharmacotherapy indefinitely or withdrawn from treatment in order to allow for the best outcomes?
This working paper was conceived to offer practical tips and suggestions on how to establish and sustain the multisectoral coordination needed to develop and implement National Action Plans on AMR (NAPs). It is intended for anyone with responsibility for addressing AMR at country level. Drawing on b
...
SECOND MEETING REPORT
DECATUR, GA, USA, 26 JUNE 2016
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t
...
The MSF qualification scheme is concerned with the pharmaceutical quality assessment for drugs. This procedure is applicable to products for international supply, i.e. products supplied through the MSF procurement centres. This qualification procedure is not applicable for local purchase, i.e. purch
...
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infec
...
Tuberculosis continues to represent a severe public health problem in the Region of the Americas, even more so in the case of indigenous peoples, whose TB incidence is much higher than that of the general population. To achieve tuberculosis control in these communities, it is necessary to respond t
...
Mpox Molecular Diagnostic Tests(RT-PCR)
recommended
March 2025. Access to appropriate, quality-assured diagnostics remains a challenge. There is limited information on key characteristics of available test kits, including their performance, reliability, and ability to detect relevant Mpox clades. Additionally, the lack of multiplex diagnostic tools c
...